The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•23 March 2026•

1 min read

Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion

Canadian flag, a plasma bag, and "GRIFOLS" text on an orange background with medical equipment, microscopes, and vials.

Key Facts

1Cencora announced it would buy the retina business of EyeSouth Partners for $1.1 billion.

2Affiliated retina physicians of EyeSouth Partners will join Cencora's Retina Consultants of America (RCA).

Version History

1 additional source confirmed this story

Cencora (NYSE: COR) has announced a definitive agreement to acquire the retina business of EyeSouth Partners for $1.1 billion in cash. The acquisition is strategically designed to expand Cencora's footprint in specialized ophthalmology management services and strengthen its physician network. Under the terms of the deal, EyeSouth's affiliated retina physicians will integrate into Cencora's Retina Consultants of America (RCA) platform. This move highlights the company's focus on scaling its specialized healthcare delivery capabilities in high-margin segments. Analysts consider the transaction a significant bolt-on acquisition that enhances Cencora's existing eye care unit. The deal is expected to drive long-term value by leveraging operational synergies within the RCA network. This expansion underscores Cencora's commitment to consolidating its leadership position in the specialized healthcare services market.